Skip to main content
MRNA
NASDAQ Life Sciences

Moderna Lifts 2026 Revenue Growth Outlook to 15%-25% From Up to 10%

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$247.31
Mkt Cap
$100.625B
52W Low
$22.28
52W High
$280.8
52W Position info
1010% above low
Off High info
12% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

MRNA has more than doubled off its 52-week low of $22.28 on light trading volume (0.3× avg).

Summary

Moderna raised its 2026 revenue growth outlook to 15%-25%, up from a prior cap of up to 10%, and guided to roughly 10 percentage points of gross margin expansion excluding a litigation settlement charge. The company also laid out about $4B in 2027 cash costs and roughly $9B of total liquidity at year-end 2026, which includes cash, investments and undrawn borrowing capacity rather than cash alone. It amended a $1.5B facility, pushing maturity to 2031, extending access to the remaining $900M through 2029 and cutting drawn-rate interest by 75 basis points. The raise lands after a strong stretch: Q3 delivered $162M of net income ($0.38 diluted EPS) on $1.3B of revenue, up 29%, and the stock had already repriced sharply on the August intismeran melanoma data. Formal 2027 guidance comes on the Q4 2026 earnings call, so this framework is not yet the full-year number.

At the time of this announcement, MRNA was trading at $247.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $100.6B. The 52-week trading range was $22.28 to $280.80. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

MRNA - Latest Insights

MRNA
Nov 07, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $256.92
Real-time Price: $230.82 info
Change: -$26.10 (-10%) info
Market Cap: $93.609B info
MRNA
Nov 06, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $255.50
Real-time Price: $230.82 info
Change: -$24.68 (-10%) info
Market Cap: $93.609B info
MRNA
Nov 06, 2026, 1:11 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $258.37
Real-time Price: $230.82 info
Change: -$27.55 (-11%) info
Market Cap: $93.609B info
MRNA
Nov 06, 2026, 7:07 AM EST
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $265.00
Real-time Price: $230.82 info
Change: -$34.18 (-13%) info
Market Cap: $93.609B info
MRNA
Nov 06, 2026, 6:47 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $252.01
Real-time Price: $230.82 info
Change: -$21.19 (-8%) info
Market Cap: $93.609B info